VX-222 (VCH-222, Lomibuvir)

inquiry

Cat No.

CEI-1577

Description

VX-222 is a potent and selective inhibitor of HCV RNA-dependent RNA polymerase with IC50 value of 0.94-1.2 μM.

Product Overview

VX-222, a derivative of thiophene-2-carboxylic acid, is a potent non-nucleoside inhibitor (NNI) of the hepatitis C virus (HCV) RNA polymerase, an enzyme regulating RNA synthesis by a de novo-initiated mechanism or by extension from a primed template, that binds to the thumb II allosteric pocket of HCV RNA-dependent RNA polymerase with hydrophobical interactions between the 4-methycyclohexanoyl group of VX-222 and L412, M423 and I482 of thumb II domain. VX-222 exhibits preferential inhibition against primer-dependent RNA synthesis rather than de novo-initiated RNA synthesis with 50% inhibition concentration IC50 values ranging from 0.011 to >5 μM in five different templates of RNA synthesis.

CAS_No

1026785-59-0

Molecular Weight

445.6

Purity

0.98

Storage

Store at -20°C

Synonyms

Lomibuvir, VCH222,VCH-222, VX222

Targets

HCV RNA polymerase

IC50

0.94-1.2 μM

Molecular Formula

C25H35NO4S

Chemical Name

5-(3,3-dimethylbut-1-ynyl)-3-[(4-hydroxycyclohexyl)-(4-methylcyclohexanecarbonyl)amino]thiophene-2-carboxylic acid

Solubility

Soluble in DMSO > 10 mM

Shipping Conditions

Evaluation sample solution: ship with blue ice. All other available size: ship with RT, or blue ice upon request

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry